Study: Nanoparticle shrinks tumor size by 80% in mouse model

Researchers from the Mayo Clinic have developed a type of cancer-fighting nanoparticle that is designed to shrink breast cancer tumors and prevent recurrence. In a mouse model, the therapy yielded a 70-80% reduction in tumor size and mice treated with the nanoparticles demonstrated resistance to future tumor recurrence a month later. The nanoparticle is coated with antibodies that target the HER2 receptor – a molecule found on 40% of breast cancers. The particles target tumors by recognizing HER2 and triggering the immune cells to attack the tumor cells. Get the full story at our sister site, Drug Delivery Business News. The post Study: Nanoparticle shrinks tumor size by 80% in mouse model appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Oncology Research & Development Mayo Clinic Source Type: news